BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25410056)

  • 1. Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.
    Hu L; Diez-Fernandez C; Rüfenacht V; Hismi BÖ; Ünal Ö; Soyucen E; Çoker M; Bayraktar BT; Gunduz M; Kiykim E; Olgac A; Pérez-Tur J; Rubio V; Häberle J
    Mol Genet Metab; 2014 Dec; 113(4):267-73. PubMed ID: 25410056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function.
    Díez-Fernández C; Hu L; Cervera J; Häberle J; Rubio V
    Mol Genet Metab; 2014 Jun; 112(2):123-32. PubMed ID: 24813853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis.
    Pekkala S; Martínez AI; Barcelona B; Yefimenko I; Finckh U; Rubio V; Cervera J
    Hum Mutat; 2010 Jul; 31(7):801-8. PubMed ID: 20578160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
    Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
    J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.
    de Cima S; Polo LM; Díez-Fernández C; Martínez AI; Cervera J; Fita I; Rubio V
    Sci Rep; 2015 Nov; 5():16950. PubMed ID: 26592762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
    Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
    Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding carbamoyl phosphate synthetase deficiency: impact of clinical mutations on enzyme functionality.
    Yefimenko I; Fresquet V; Marco-Marín C; Rubio V; Cervera J
    J Mol Biol; 2005 May; 349(1):127-41. PubMed ID: 15876373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
    Diez-Fernandez C; Häberle J
    Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency.
    Martínez AI; Pérez-Arellano I; Pekkala S; Barcelona B; Cervera J
    Mol Genet Metab; 2010 Dec; 101(4):311-23. PubMed ID: 20800523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
    Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
    Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamoylphosphate synthetase 1 (CPS1) deficiency: clinical, biochemical, and molecular characterization in Malaysian patients.
    Ali EZ; Khalid MK; Yunus ZM; Yakob Y; Chin CB; Abd Latif K; Hock NL
    Eur J Pediatr; 2016 Mar; 175(3):339-46. PubMed ID: 26440671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A constitutive knockout of murine carbamoyl phosphate synthetase 1 results in death with marked hyperglutaminemia and hyperammonemia.
    Khoja S; Nitzahn M; Truong B; Lambert J; Willis B; Allegri G; Rüfenacht V; Häberle J; Lipshutz GS
    J Inherit Metab Dis; 2019 Nov; 42(6):1044-1053. PubMed ID: 30835861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural organization of the human carbamyl phosphate synthetase I gene (CPS1) and identification of two novel genetic lesions.
    Funghini S; Donati MA; Pasquini E; Zammarchi E; Morrone A
    Hum Mutat; 2003 Oct; 22(4):340-1. PubMed ID: 12955727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing.
    Choi R; Park HD; Yang M; Ki CS; Lee SY; Kim JW; Song J; Chang YS; Park WS
    Ann Lab Med; 2017 Jan; 37(1):58-62. PubMed ID: 27834067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J
    Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of CPS1 gene mutation in a neonate with carbamoyl phosphate synthetase I deficiency].
    Zhang H; Lang Y; Zhang K; Li X; Liu Y; Gai Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):848-851. PubMed ID: 30512161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort.
    Funghini S; Thusberg J; Spada M; Gasperini S; Parini R; Ventura L; Meli C; De Cosmo L; Sibilio M; Mooney SD; Guerrini R; Donati MA; Morrone A
    Gene; 2012 Feb; 493(2):228-34. PubMed ID: 22173106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.
    Chen X; Yuan L; Sun M; Liu Q; Wu Y
    J Clin Lab Anal; 2018 Jun; 32(5):e22375. PubMed ID: 29314318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.
    Shi D; Zhao G; Ah Mew N; Tuchman M
    Mol Genet Metab; 2017 Mar; 120(3):198-206. PubMed ID: 28007335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.